Cytokine. 2016 Dec;88:281-286. doi: 10.1016/j.cyto.2016.09.025. Epub 2016 Oct 6.

Alternative pathway regulation by factor H modulates Streptococcus pneumoniae induced proinflammatory cytokine responses by decreasing C5a receptor crosstalk.

van der Maten E1, de Bont CM1, de Groot R1, de Jonge MI1, Langereis JD1, van der Flier M2.

Author information

Abstract

Bacterial pathogens not only stimulate innate immune receptors, but also activate the complement system. Crosstalk between complement C5a receptor (C5aR) and other innate immune receptors is known to enhance the proinflammatory cytokine response. An important determinant of the magnitude of complement activation is the activity of the alternative pathway, which serves as an amplification mechanism for complement activation. Both alternative pathway activity as well as plasma levels of factor H, a key inhibitor of the alternative pathway, show large variation within the human population. Here, we studied the effect of factor H-mediated regulation of the alternative pathway on bacterial-induced proinflammatory cytokine responses. We used the human pathogen Streptococcus pneumoniae as a model stimulus to induce proinflammatory cytokine responses in human peripheral blood mononuclear cells. Serum containing active complement enhanced pneumococcal induced proinflammatory cytokine production through C5a release and C5aR crosstalk. We found that inhibition of the alternative pathway by factor H, with a concentration equivalent to a high physiological level, strongly reduced C5a levels and decreased proinflammatory cytokine production in human peripheral blood mononuclear cells. This suggests that variation in alternative pathway activity due to variation in factor H plasma levels affects individual cytokine responses during infection.

Copyright © 2016 Elsevier Ltd. All rights reserved.

KEYWORDS:

Alternative pathway; C5aR crosstalk; Complement; Factor H; Proinflammatory cytokines; Streptococcus pneumoniae

PMID: 27721145 DOI: 10.1016/j.cyto.2016.09.025

 

[PubMed - in process]